Form 8-K - Current report:
SEC Accession No. 0001193125-25-023995
Filing Date
2025-02-11
Accepted
2025-02-11 08:00:22
Documents
13
Period of Report
2025-02-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K d867173d8k.htm   iXBRL 8-K 29784
  Complete submission text file 0001193125-25-023995.txt   157776

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA thrd-20250211.xsd EX-101.SCH 2865
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE thrd-20250211_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thrd-20250211_pre.xml EX-101.PRE 11717
15 EXTRACTED XBRL INSTANCE DOCUMENT d867173d8k_htm.xml XML 3776
Mailing Address 1700 MONTGOMERY STREET SUITE 210 SAN FRANCISCO CA 94111
Business Address 1700 MONTGOMERY STREET SUITE 210 SAN FRANCISCO CA 94111 2097272457
Third Harmonic Bio, Inc. (Filer) CIK: 0001923840 (see all company filings)

EIN.: 834553503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41498 | Film No.: 25607712
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)